Wegovy (semaglutide) is an injectable medication thats approved by the Food and Drug Administration for chronic weight management and to reduce the risk of cardiovascular disease in people with obesity or who are overweight
The active ingredient in both drugs is semaglutide, a Experts describe the development of oral GLP-1 medication as a pivotal improvement in the accessibility and adherence to obesity drugs
However, no studies demonstrate improvement in thyroid-specific outcomes such as antibody titers, thyroid hormone levels, or disease progression
Build your full advantage
(Low Wangs views do not represent those of the FDA or the FDA Endocrinologic and Metabolic Drugs Advisory Committee.) How much weight can people lose with retatrutide
As part of the plan, customers are offered a choice from a range of GLP-1 drugs, including Mounjaro, Saxenda, Rybelsus, Trulicity, Victoza, and Wegovy